335 related articles for article (PubMed ID: 9819031)
1. Interaction of activated factor VII and active site-inhibited activated factor VII with tissue factor.
Sørensen BB; Rao LV
Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S67-71. PubMed ID: 9819031
[TBL] [Abstract][Full Text] [Related]
2. Large enhancement of functional activity of active site-inhibited factor VIIa due to protein dimerization: insights into mechanism of assembly/disassembly from tissue factor.
Stone MD; Harvey SB; Martinez MB; Bach RR; Nelsestuen GL
Biochemistry; 2005 Apr; 44(16):6321-30. PubMed ID: 15835921
[TBL] [Abstract][Full Text] [Related]
3. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M
Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470
[TBL] [Abstract][Full Text] [Related]
4. Tissue factor binding of activated factor VII triggers smooth muscle cell proliferation via extracellular signal-regulated kinase activation.
Cirillo P; Calì G; Golino P; Calabrò P; Forte L; De Rosa S; Pacileo M; Ragni M; Scopacasa F; Nitsch L; Chiariello M
Circulation; 2004 Jun; 109(23):2911-6. PubMed ID: 15173027
[TBL] [Abstract][Full Text] [Related]
5. Characterization of recombinant murine factor VIIa and recombinant murine tissue factor: a human-murine species compatibility study.
Petersen LC; Nørby PL; Branner S; Sørensen BB; Elm T; Stennicke HR; Persson E; Bjørn SE
Thromb Res; 2005; 116(1):75-85. PubMed ID: 15850611
[TBL] [Abstract][Full Text] [Related]
6. The effects of activated factor VII in a cell-based model for tissue factor-initiated coagulation.
Kjalke M; Monroe DM; Hoffman M; Oliver JA; Ezban M; Hedner U; Roberts HR
Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S21-5. PubMed ID: 9819025
[TBL] [Abstract][Full Text] [Related]
7. Tissue factor on cells.
Rao LV; Pendurthi UR
Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S27-35. PubMed ID: 9819026
[TBL] [Abstract][Full Text] [Related]
8. Active site-blocked activated factor VII as an effective antithrombotic agent: mechanism of action.
Rao LV; Ezban M
Blood Coagul Fibrinolysis; 2000 Apr; 11 Suppl 1():S135-43. PubMed ID: 10850580
[TBL] [Abstract][Full Text] [Related]
9. Ca2+ in the first epidermal growth factor-like domain of activated factor VII.
Persson E; Nielsen LS
Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S79-81. PubMed ID: 9819033
[TBL] [Abstract][Full Text] [Related]
10. Two independent binding sites on monolayers of human endothelial cells are responsible for interaction with coagulation factor VII and factor VIIa.
Reuning U; Preissner KT; Müller-Berghaus G
Thromb Haemost; 1993 Feb; 69(2):197-204. PubMed ID: 8456434
[TBL] [Abstract][Full Text] [Related]
11. Coagulation factors VIIa and Xa inhibit apoptosis and anoikis.
Versteeg HH; Spek CA; Richel DJ; Peppelenbosch MP
Oncogene; 2004 Jan; 23(2):410-7. PubMed ID: 14724569
[TBL] [Abstract][Full Text] [Related]
12. The tissue factor/factor VIIa/factor Xa complex: a model built by docking and site-directed mutagenesis.
Norledge BV; Petrovan RJ; Ruf W; Olson AJ
Proteins; 2003 Nov; 53(3):640-8. PubMed ID: 14579355
[TBL] [Abstract][Full Text] [Related]
13. The antithrombotic and anti-inflammatory effects of BCX-3607, a small molecule tissue factor/factor VIIa inhibitor.
Arnold CS; Parker C; Upshaw R; Prydz H; Chand P; Kotian P; Bantia S; Babu YS
Thromb Res; 2006; 117(3):343-9. PubMed ID: 16378835
[TBL] [Abstract][Full Text] [Related]
14. Enhancing the anticoagulant potency of soluble tissue factor mutants by increasing their affinity to factor VIIa.
Yang J; Lee GF; Riederer MA; Kelley RF
Thromb Haemost; 2002 Mar; 87(3):450-8. PubMed ID: 11916078
[TBL] [Abstract][Full Text] [Related]
15. Differential gene expression in activated monocyte-derived macrophages following binding of factor VIIa to tissue factor.
Muth H; Kreis I; Zimmermann R; Tillmanns H; Hölschermann H
Thromb Haemost; 2005 Nov; 94(5):1028-34. PubMed ID: 16363246
[TBL] [Abstract][Full Text] [Related]
16. Antithrombotic effects of recombinant human, active site-blocked factor VIIa in a rabbit model of recurrent arterial thrombosis.
Golino P; Ragni M; Cirillo P; D'Andrea D; Scognamiglio A; Ravera A; Buono C; Ezban M; Corcione N; Vigorito F; Condorelli M; Chiariello M
Circ Res; 1998 Jan 9-23; 82(1):39-46. PubMed ID: 9440703
[TBL] [Abstract][Full Text] [Related]
17. Tissue factor pathway inhibitor inhibits aortic smooth muscle cell migration induced by tissue factor/factor VIIa complex.
Sato Y; Asada Y; Marutsuka K; Hatakeyama K; Kamikubo Y; Sumiyoshi A
Thromb Haemost; 1997 Sep; 78(3):1138-41. PubMed ID: 9308767
[TBL] [Abstract][Full Text] [Related]
18. Rational design of coagulation factor VIIa variants with substantially increased intrinsic activity.
Persson E; Kjalke M; Olsen OH
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13583-8. PubMed ID: 11698657
[TBL] [Abstract][Full Text] [Related]
19. Similar molecular interactions of factor VII and factor VIIa with the tissue factor region that allosterically regulates enzyme activity.
Kelley RF; Yang J; Eigenbrot C; Moran P; Peek M; Lipari MT; Kirchhofer D
Biochemistry; 2004 Feb; 43(5):1223-9. PubMed ID: 14756558
[TBL] [Abstract][Full Text] [Related]
20. Activation loop 3 and the 170 loop interact in the active conformation of coagulation factor VIIa.
Persson E; Olsen OH
FEBS J; 2009 Jun; 276(11):3099-109. PubMed ID: 19490111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]